1Biondi-Zoccai G G, Agostoni P, Abbate A, et el. Adjusted indirect comparison of intraoomnary drug-eluting stents: Evidence from a meta analysis of randomized bare-metal-stent controlled trials[J]. Int J Cardiol, 2005, 100(1) : 119.
3Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents[J]. JAMA, 2005, 293: 2126.
4Joner M, Finn A V, Farb A, et al. Pathology of drug-eluting stents in humans; delayed healing and late thrombotic risk [J]. J Am Coll Cardial, 2006, 48: 193.
5Marx S O, Jayaman T, Go L O, et al. Rapamycin FKBP inhibits cell cycle regulators on vascular smooth muscle cells[J]. Circ Res, 1995, 76(3): 412.
6Gregory c, Huie P, Shorthouse R, et al. Treatment with rapamycin blocks arterial intimal thickening following mechanical and allioim-mune injury[J ]. Transplant Proc, 1993, 25 ( 1 ) :120.
2Cripps TR,Malik M,Farrell TG,et al.Prognostic value of reduced heart rate variability after myocardial infarction[J].Br Heart J,1991,65(1):14-19.
3Lanza GA,Pedrotti P,Rebuzzi AG,et al.Usefulness of the addition of heart rate variability to holter monitoring in predicting in-hospital cardiac events in patients with unstable angina pectoris[J].Am J Cardiol,1997,80(3):263-267.
10Dibra A, Kastrati A, Alfonso F,et al. Effectiveness of drug- eluting stents in patients with bare-metal in-stem restenosis: recta-analysis of randomized trials[J] J Am Coil Cardiol, 2007,49(5) :616-623.
